T 1121/23 (Targeted RNA Editing/PROQR THERAPEUTICS II) of 30.09.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T112123.20250930
- Date of decision
- 30 September 2025
- Case number
- T 1121/23
- Petition for review of
- -
- Application number
- 15813826.3
- IPC class
- C12N 15/113
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TARGETED RNA EDITING
- Applicant name
- ProQR Therapeutics II B.V.
- Opponent name
- STRAWMAN LIMITED
Margaret Dixon Limited - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 012(4)
- Keywords
- Main request and Auxiliary request 7, 14 to 18 - novelty (no)
Auxiliary requests 12, 13, 19 to 23 - inventive step (no)
Auxiliary requests 24 to 27 - added subject-matter (yes),
Admission of new evidence (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.